Peptide Therapies for Diabetic Eye Disease
Explore peptide research and guides on peptide therapies for diabetic eye disease.
Peptide Therapies for Diabetic Eye Disease
GLP-1 Agonists and Retinal Health: Help or Harm?
Semaglutide raised diabetic retinopathy concerns in SUSTAIN-6, but real-world data shows a different picture. The full evidence on GLP-1 drugs and eye health.
Peptide Therapies for Diabetic Eye DiseasePeptide Therapies for Diabetic Eye Disease
From GLP-1 agonists to PEDF eye drops, peptide-based approaches to diabetic retinopathy span neuroprotection, anti-VEGF, and metabolic pathways.